ClinicalTrials.Veeva

Menu

Phenytoin in the Healing of Clean Surgical Wounds

C

Children's Surgical Center, Cambodia

Status and phase

Unknown
Phase 2

Conditions

Wound
Re-Epithelialization

Treatments

Drug: Phenytoin
Drug: Sugar solution

Study type

Interventional

Funder types

Other

Identifiers

NCT02413658
1CSC2015

Details and patient eligibility

About

The purpose of this study is to investigate the potential healing properties of phenytoin.

The investigators will use the donor site of a split skin thickness graft (SSTG) to model a basic wound in a randomized controlled trial of topical phenytoin against current best clinical practice. The investigators aim to demonstrate a dose dependent effect. The investigators hypothesis, based on previous clinical experience at our center and on current available literature, that phenytoin will reduce wound healing time.

Enrollment

100 estimated patients

Sex

All

Ages

Under 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Undergoing split thickness skin graft during trial time period at Children's Surgical Centre

Exclusion Criteria:

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

100 participants in 3 patient groups

Control
Active Comparator group
Description:
Dressings of best current clinical practice, sugar solution.
Treatment:
Drug: Sugar solution
Phenytoin 1
Experimental group
Description:
Dressings using phenytoin solution 20mg/ml
Treatment:
Drug: Phenytoin
Phenytoin 2
Experimental group
Description:
Dressings using phenytoin solution 40mg/ml
Treatment:
Drug: Phenytoin

Trial contacts and locations

1

Loading...

Central trial contact

Jim Gollogly

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems